Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1980-05-16
1981-04-14
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
A61K 3700
Patent
active
042619807
ABSTRACT:
Polypeptides which are useful in the prophylaxis and treatment of sickle cell disease are represented by the formula: ##STR1## wherein X is Val or Gln; Y is Pro or dehydroPro; Z is a residue of a basic amino acid with a side chain in the D-configuration; and A is a disulfide or monocarba radical, with the proviso that when X is Gln, Y is Pro and Z is D-Arg, then A is mono-carba.
REFERENCES:
Development of Therapeutic Agents for Sickle Cell Disease, INSERM Symposium No. 9, Rosa et al., 1979 Elsevier, North-Holland Biomed. Press, pp. 129-137.
Vega Laboratories, Inc.
Waddell Frederick E.
LandOfFree
Method for prophylaxis and/or treatment of sickle cell disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for prophylaxis and/or treatment of sickle cell disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for prophylaxis and/or treatment of sickle cell disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-158996